|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Net losses on financial instruments | |||||
| Gain on sale of business | |||||
| Equity in net (earnings) losses of other invested assets | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Impairment of property, equipment and right-of-use assets | |||||
| Share-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables, net | |||||
| Other invested assets | |||||
| Other assets | |||||
| Policy liabilities | |||||
| Unearned income | |||||
| Accounts payable and other liabilities | |||||
| Income taxes | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Maturities, calls and redemptions from investments | |||||
| Changes in securities lending collateral | |||||
| Purchases of subsidiaries, net of cash acquired | |||||
| Proceeds from sales of subsidiaries, net of cash sold | |||||
| Purchases of property and equipment | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from long-term borrowings, net issuance costs | |||||
| Repayments of long-term borrowings | |||||
| Proceeds from short-term borrowings | |||||
| Repayments of short-term borrowings | |||||
| Changes in securities lending payable | |||||
| Changes in bank overdrafts | |||||
| Repurchase and retirement of common stock | |||||
| Cash dividends | |||||
| Proceeds from issuance of common stock under employee stock plans | |||||
| Taxes paid through withholding of common stock under employee stock plans | |||||
| Other, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rates on cash and cash equivalents | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Less cash and cash equivalents included in assets held for sale at end of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...